Look at these 5 eye-catching NZX healthcare stocks

3 min read | October 03, 2021 12:00 AM NZDT | By Roma

Highlights

  • COGA evaluation, YTD sales growth noted by TruScreen.
  • Management changes and additions made to Blis Technologies and Fisher and Paykel’s Board.
  • GMP Manufacturing licence received by Rua Bioscience.

The healthcare industry has seen major changes in the past year and a half. From being in constant demand as frontliners are fighting a battle against COVID-19 to providing other kinds of critical care to patients suffering from critical illnesses, healthcare stocks in the country have had their share of ups and downs.

Given the above background, have a look at 5 such healthcare stocks.

NZX Healthcare stocks -FPH, TRU, PHL, BLT, RUA

Image source: © 2021 Kalkine Media New Zealand Lt; data source: EODHD/Others

Fisher and Paykel Healthcare Corporation Limited(NZX:FPH)

Dealing in the design production and manufacture of several critical care equipment, Fisher and Paykel is especially known for its respiratory solutions.

In an announcement made last month, Lisa McIntyre was appointed to the Board of the company as a non-executive director and shall take office from 1 October 2021. Her experience in healthcare, technology and insurance shall be of great use to the company.

On 1 October 2021, the Company last traded at NZ$31.27, down by 0.88%.

Read now: Are these 5 cheapest NZX healthcare stocks?

TruScreen Group Limited (NZX:TRU)

The Company offers state-of-the-art Screening Solutions, which are especially helpful in situations when going to a laboratory facility might be difficult.

In its last newsletter, the Company declared that its YTD sales have witnessed a 36% growth in the period from April to August 2021 as compared to April to August 2020. It has also completed the much-awaited COGA evaluation.

On 1 October 2021, the Company last traded at NZ$0.060, up by 1.69%.

Promisia Healthcare Limited(NZX:PHL)

Offering aged care facilities in New Zealand, it is known to be home to hundreds of residents.

The most recent announcement made by the Company was the acknowledgement of the banking covenant breach that occurred a while ago. It is related to interest Cover and EBITDA, which would be responsible for covering about 2 times the cost of interest.

On 1 October 2021, the Company last traded flat at NZ$0.002.

Also read: Which are the 5 penny stocks from healthcare space?

Blis Technologies Limited (NZX:BLT)

This is a primary a manufacturer of various kinds of probiotics in the country, which has a number of applications like healthcare and beauty.

While the chief marketing officer for the company Julie Curphey handed in her resignation effective from 29 October 2021, Tomm Ronnlund has joined the company as a director from 22 July 2021.

On 1 October 2021, the Company last traded flat at NZ$0.065.

Rua Bioscience Limited (NZX:RUA)

This Company deals in the manufacture of cannabis-related medical products. Recently, the company announced receiving its GMP manufacture licence and the first product it shall produce is set to be a type of cannabinoid oil. This is the global certification required for ensuring the safety and acceptability of any pharmaceutical product.

On 1 October 2021, the Company last traded flat at NZ$0.415.

Bottom Line

In any economy across the world, one of the biggest and the most complex sector is healthcare. It has a wide range of organisations dealing in medicines, medical services and equipment.  

Investors can consider this sector while diversifying their portfolio, which could add extra zing to it.


Disclaimer

The content on this website, including, but not limited to, any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (“Content”) is a service provided by Kalkine Media New Zealand Limited (Kalkine Media, we or us) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide financial advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests users seek financial advice from a financial advice provider, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all liability to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without any express or implied warranties of any kind. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit a source wherever it is indicated or is found to be necessary or desirable.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.